The mechanism behind Aurogra 100 involves its active ingredient, sildenafil citrate, which acts as a potent inhibitor of the enzyme phosphodiesterase type 5 (PDE5). When a man is sexually aroused, nitric oxide is released in the erectile tissue of the penis, which stimulates the production of cGMP. This cGMP is responsible for relaxing the smooth muscles of the penile blood vessels, allowing increased blood flow into the penis, resulting in an erection. However, PDE5 breaks down cGMP, leading to a decrease in blood flow and subsequent loss of erection. Aurogra 100 inhibits PDE5, allowing cGMP levels to remain elevated, promoting sustained penile vasodilation and erection during sexual stimulation. This mechanism underscores Aurogra 100’s effectiveness in treating erectile dysfunction by facilitating improved blood circulation to the penis, enabling satisfactory sexual performance.
